financetom
Business
financetom
/
Business
/
Entegris Insider Sold Shares Worth $265,806, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Entegris Insider Sold Shares Worth $265,806, According to a Recent SEC Filing
May 17, 2024 12:28 PM

03:07 PM EDT, 05/17/2024 (MT Newswires) -- Olivier Blachier, Senior Vice President, Chief Strategy Officer, on May 16, 2024, sold 1,986 shares in Entegris ( ENTG ) for $265,806. Following the Form 4 filing with the SEC, Blachier has control over a total of 12,356 shares of the company, with 12,356 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1101302/000189166124000006/xslF345X03/wk-form4_1715972625.xml

Price: 129.41, Change: -1.16, Percent Change: -0.89

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
AIM ImmunoTech Says Ampligen Combination 'Well-Tolerated' in Pancreatic Cancer
AIM ImmunoTech Says Ampligen Combination 'Well-Tolerated' in Pancreatic Cancer
Jul 28, 2025
09:59 AM EDT, 07/28/2025 (MT Newswires) -- AIM ImmunoTech ( AIM ) said Monday that midyear data from a phase 2 trial showed that Ampligen with AstraZeneca's ( AZN ) Imfinzi is well-tolerated in post-Folfirinox pancreatic cancer patients, with the combination treatment showing signs of no significant toxicity and better-than-expected survival data. The company said about 21% of the patients...
Bausch Health to Reduce Debt by More Than $900 Million Through Note Redemption, Facility Repayment
Bausch Health to Reduce Debt by More Than $900 Million Through Note Redemption, Facility Repayment
Jul 28, 2025
10:00 AM EDT, 07/28/2025 (MT Newswires) -- Bausch Health ( BHC ) said Monday it plans to reduce debt by more than $900 million through note redemption and repayment of amounts under a receivables financing facility. The company said its subsidiary, Bausch Health Americas, intends to redeem on Aug. 28 about $602 million of its outstanding 9.25% senior notes due...
Interfor Renews and Extends Credit Facilities
Interfor Renews and Extends Credit Facilities
Jul 28, 2025
09:57 AM EDT, 07/28/2025 (MT Newswires) -- Interfor ( IFSPF ) on Monday said it recently closed an early renewal and extension of its revolving credit facility with its syndicate of major Canadian and U.S. banks. The commitment amount under the facility was renewed at approximately $560 million, and the maturity of the facility was extended from December 2026 to...
Copyright 2023-2026 - www.financetom.com All Rights Reserved